Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Revlon

This article was originally published in The Rose Sheet

Executive Summary

Revlon: Signs $750 mil. credit facility to refinance, "at lower interest rates and on more favorable terms," the company's existing $600 mil. facility, Revlon announced June 3. The new credit agreement will also redeem the firm's 10-7/8% Sinking Fund Debentures, due 2010. Revlon anticipates it will redeem the debentures "on or about" July 15. In connection with the new facility, the company expects to register an extraordinary item in the second quarter (ending June 30) "related to the early extinguishment of debt," Revlon stated...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel